MedPath

MALIGNANCY RISK STRATIFICATION OF THYROID NODULES: COMPARISON BETWEEN THE AMERICAN COLLEGE OF RADIOLOGY THYROID IMAGING REPORTING AND DATA SYSTEM (ACR TI-RADS) AND THE AMERICAN THYROID ASSOCIATION (ATA) MANAGEMENT GUIDELINES

Completed
Conditions
ACR TI-RADS recommend for follow up if size of thyroid nodule is less than 1.5 cm.
ACR TI-RADS ATA-guidelines
Registration Number
TCTR20230208002
Lead Sponsor
AMPANG HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
83
Inclusion Criteria

1. Thyroid nodule with suspicious findings of malignancy.
2. Thyroid function test (FT3, FT4 or TSH)
3. Proven tissue path (FNA or thyroidectomy)

Exclusion Criteria

1. Thyroid nodules size less than 10 mm.
2. Missing some FT3, FT4 or TSH
3. The pre-biopsy imaging were performed from another medical center.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Malignancy Risk at 12 months after end of the intervention ACR TI-RADS
Secondary Outcome Measures
NameTimeMethod
Malignancy Risk. at 12 months after end of the intervention ATA guidelines
© Copyright 2025. All Rights Reserved by MedPath